CATEGORY : Biomarkers

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

Pain Points, Unmet Needs, and Disruption in Precision Medicine – Part 1

DeciBio’s mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry. To this end, my colleague, Colin Enderlein,

Highly-Multiplexed Tissue Imaging: The Research Tool of The Future

In our last blog post, Andrew covered how immuno-oncology is driving the development and utilization of digital pathology and multiplex spatial tissue analysis. In his blog, Andrew included all plex

Pulse Survey: Adoption and Utilization of Next Generation Cancer Biomarkers

The way cancer is diagnosed, treated, and monitored is changing more rapidly than ever. In 2019, we expect there to be catalysts that fundamentally change cancer companion diagnostic biomarker testing (i.e.,

Three lessons for digital health entrepreneurs from #RHSUM18

This year’s Rock Health annual digital health summit showcased another impressive lineup, with speakers like Bernard Tyson (CEO of Kaiser Permanente), Toby Cosgrove (Executive Adviser for Google Cloud and former

AGBT Precision Health 2018 Highlights: Precision Medicine Builds Up Steam Outside Academia

We attended AGBT Precision Health and had a chance to speak with pathologists, researchers, tools manufacturers, and other precision medicine stakeholders and thought leaders. The conference is finding its identity, as

Think Twice Before Divesting CRISPR Amid Cancer Concerns

Why Headlines Linking CRISPR to Cancer are Misleading Investors Two papers published by Novartis and Karolinska Institute that warn of potential cancer risks associated with CRISPR-Cas9 editing sent share prices

CRISPRcon 2018 Highlights

Takeaways from Conversations on Science, Society, and the Future of Gene Editing At CRISPRcon, DeciBio had the opportunity to participate in discussions with leading scientists, industry professionals, bioethicists, regulators, community

ASCO 2018 Summary Highlights

Is Neoantigen Load the next TMB? The rise of cfRNA and the Saturation of the Liquid Biopsy Landscape Another ASCO Annual Meeting has come to a close and, though this

Liquid Biopsy Trends to Watch at ASCO 2018

Guardant leads, Grail makes strides with CCGA, and more Over 39,000 attendees are expected to descend upon McCormick Place in just one short week. The theme for this year’s conference,